ATE110770T1 - Proliferation von cd4-lymfocyten. - Google Patents
Proliferation von cd4-lymfocyten.Info
- Publication number
- ATE110770T1 ATE110770T1 AT90904107T AT90904107T ATE110770T1 AT E110770 T1 ATE110770 T1 AT E110770T1 AT 90904107 T AT90904107 T AT 90904107T AT 90904107 T AT90904107 T AT 90904107T AT E110770 T1 ATE110770 T1 AT E110770T1
- Authority
- AT
- Austria
- Prior art keywords
- lymphocytes
- methyl ester
- leucine methyl
- alkyl ester
- lymfocytes
- Prior art date
Links
- 230000035755 proliferation Effects 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 3
- AJMOLNFDYWTVQW-QWRGUYRKSA-N L-leucyl-l-leucine methyl ester Chemical compound COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C AJMOLNFDYWTVQW-QWRGUYRKSA-N 0.000 abstract 2
- 108010062054 leucyl-leucine-methyl ester Proteins 0.000 abstract 2
- QVDXUKJJGUSGLS-LURJTMIESA-N methyl L-leucinate Chemical compound COC(=O)[C@@H](N)CC(C)C QVDXUKJJGUSGLS-LURJTMIESA-N 0.000 abstract 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 abstract 2
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 102000000588 Interleukin-2 Human genes 0.000 abstract 1
- 108010002350 Interleukin-2 Proteins 0.000 abstract 1
- 229940122760 T cell stimulant Drugs 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31342189A | 1989-02-21 | 1989-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE110770T1 true ATE110770T1 (de) | 1994-09-15 |
Family
ID=23215624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90904107T ATE110770T1 (de) | 1989-02-21 | 1990-02-08 | Proliferation von cd4-lymfocyten. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0460065B1 (de) |
AT (1) | ATE110770T1 (de) |
AU (1) | AU645488B2 (de) |
DE (1) | DE69012105T2 (de) |
DK (1) | DK0460065T3 (de) |
HU (1) | HU902289D0 (de) |
WO (1) | WO1990010059A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9200161A (es) * | 1991-01-16 | 1992-07-01 | Schering Corp | Uso de interleucina-10 en inmunoterapia adoptiva de cancer |
US5374549A (en) * | 1991-01-31 | 1994-12-20 | Terumo Corporation | Process of enriching adherent CD4+ T cells from monocyte depleted peripheral blood mononuclear cells with interleukin 2 and interleukin 4 |
DE4410136A1 (de) | 1993-03-31 | 1994-10-06 | Boehringer Mannheim Gmbh | Tumorizide T-Lymphozyten |
US6652850B1 (en) | 1993-09-13 | 2003-11-25 | Aventis Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
US5834441A (en) * | 1993-09-13 | 1998-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral (AAV) liposomes and methods related thereto |
CA2206449A1 (en) * | 1994-12-01 | 1996-06-06 | Beth Israel Deaconess Medical Center, Inc. | In vitro t-lymphopoiesis system |
CN107502589A (zh) * | 2017-08-04 | 2017-12-22 | 北京世纪劲得生物技术有限公司 | 一种肿瘤浸润淋巴细胞与单个核细胞共培养方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4849329A (en) * | 1986-05-30 | 1989-07-18 | E. I. Du Pont De Nemours And Company | Process for preparing lymphokine activated killer cells |
SE459008B (sv) * | 1986-09-04 | 1989-05-29 | Bioinvent Int Ab | Saett att framsstaella humana monoklonala antikroppar |
CA1300058C (en) * | 1987-01-29 | 1992-05-05 | Joseph D. Irr | Process for preparing activated killer cells |
US4808151A (en) * | 1987-04-27 | 1989-02-28 | E. I. Du Pont De Nemours And Company | Simplified method for the preparation of human lymphokine activated killer cells |
SE461985B (sv) * | 1988-09-13 | 1990-04-23 | Bioinvent Int Ab | In vitro immunisering av lymfocytinnehaallande cellpopulationer och materialsats daerfoer |
-
1990
- 1990-02-08 HU HU902289A patent/HU902289D0/hu unknown
- 1990-02-08 WO PCT/US1990/000611 patent/WO1990010059A1/en active IP Right Grant
- 1990-02-08 AT AT90904107T patent/ATE110770T1/de not_active IP Right Cessation
- 1990-02-08 DE DE69012105T patent/DE69012105T2/de not_active Expired - Fee Related
- 1990-02-08 AU AU51965/90A patent/AU645488B2/en not_active Ceased
- 1990-02-08 EP EP90904107A patent/EP0460065B1/de not_active Expired - Lifetime
- 1990-02-08 DK DK90904107.1T patent/DK0460065T3/da active
Also Published As
Publication number | Publication date |
---|---|
DE69012105T2 (de) | 1994-12-22 |
HU902289D0 (en) | 1991-11-28 |
AU645488B2 (en) | 1994-01-20 |
DE69012105D1 (en) | 1994-10-06 |
EP0460065A1 (de) | 1991-12-11 |
EP0460065B1 (de) | 1994-08-31 |
AU5196590A (en) | 1990-09-26 |
WO1990010059A1 (en) | 1990-09-07 |
DK0460065T3 (da) | 1994-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5598118A (en) | Preparation of type-2 interferon and drug containing the same | |
DK0504177T3 (da) | IL-11, et pattedyrcytokin | |
ATE204019T1 (de) | Steigerung der transplantattoleranz durch schwein cytokine | |
ATE250426T1 (de) | Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts | |
DK0414475T3 (da) | Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier | |
Hoyer et al. | Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction | |
CA2021500A1 (en) | Method for stimulating proliferation of peripheral blood lymphocytes | |
DE69012105T2 (de) | Proliferation von cd4-lymfocyten. | |
Brooks | NK cell cloning technology and characteristics of NK cell clones | |
Smith et al. | Inhibition of cells in culture by polyamines does not depend on the presence of ruminant serum | |
EP0483237B1 (de) | Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen | |
DE69528473T2 (de) | Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen | |
JPS6447372A (en) | Cell culture film carrier | |
FI960839A (fi) | Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa | |
AU6044090A (en) | Preparation of human adherent lymphokine-activated killer (a-lak) cells | |
EP0257962A3 (de) | Verfahren zur Behandlung von Umkreisblut für die Verbesserung der lymphokinaktivierten Töterzell-Immuntherapie | |
Blomgren et al. | Regulation of lymphocyte proliferation by soluble products released by stimulated human lymphocytes | |
AU3927895A (en) | Lipid-splitting enzyme | |
Brenner | 6 Haematological applications of interleukin-2 and other immunostimulatory cytokines | |
Wagner et al. | Heterogeneity of the signal requirements during the primary activation of resting Lyt-2+ cytotoxic T-lymphocyte (CTL) precursors into clonally developing CTL | |
Human et al. | STEVEN COUTRE, STEVEN KH FOUNG, AND EDGAR G. ENGLEMAN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |